Clinical Trial Update: Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating predictive algorithms to reduce nocturnal hypoglycemia and hyperglycemia in home settings for Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED